Skip to main content
Fig. 1 | The Journal of Headache and Pain

Fig. 1

From: Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment

Fig. 1

Change in percentage of HI (upper) and AC (lower) from T6 to T18 compared to baseline. Our observational results confirmed that already after 2 treatment cycles the HI was powerfully reduced of 22 % vs the baseline value and it kept consistently reducing overtime down to 34 % at T18 (at the cycle 7). This clinical improvement was further raised up by a simultaneous marked trend of reduction in AC vs the basal status that reached a 67 % at T18

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us